{"count":13,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/93042e88-a4d4-44ef-9564-4483c3c7ae06/","filing_uuid":"93042e88-a4d4-44ef-9564-4483c3c7ae06","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/93042e88-a4d4-44ef-9564-4483c3c7ae06/print/","filing_document_content_type":"text/html","income":null,"expenses":"337175.94","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Garrett Eberhardt","dt_posted":"2026-04-09T09:41:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1350 I Street NW","registrant_address_2":"Suite 800","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":316434,"url":"https://lda.gov/api/v1/registrants/316434/","house_registrant_id":39137,"name":"340B HEALTH","description":"A non-profit hospital association representing hospitals enrolled in the 340B program.","address_1":"1350 I Street NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PATRICK MCGARY","contact_telephone":"+1 202-552-5820","dt_updated":"2026-07-27T13:55:36.949437-04:00"},"client":{"id":185829,"url":"https://lda.gov/api/v1/clients/185829/","client_id":12,"name":"340B HEALTH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-05-06"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"340B Drug Rebate Proposals, Contract Pharmacy - 340B PATIENTS Act reintroduction in the House and Senate; Budget reconciliation, H Con Res 14, House & Senate Budget Resolution; H.R.44: To amend title III of the Public Health Service Act to include rural emergency hospitals in the definition of a covered entity for purposes of the 340B drug discount program; S. 523: A bill to amend title XIX of the Social Security Act to prohibit Federal Medicaid funding for the administrative costs of providing health benefits to individuals who are unauthorized immigrants; H.R.1195: To amend title XIX of the Social Security Act to prohibit Federal Medicaid funding for the administrative costs of providing health benefits to individuals who are unauthorized immigrants; PBM, Reintroduction of 340B PROTECT Act in the House; FY 2026 Labor HHS Appropriations Act, House & Senate; Draft Senate 340B reform legislation - 340B SUSTAIN Act; HR 2197, No 340B Savings for Transgender Care Act; Implementation of the Inflation Reduction Act; S.891 - Bipartisan Health Care Act, HR1, the One BIg Beautiful Bill, Budget Reconciliation, H.R. 5256, 340B ACCESS Act; H.R. 7391 - Community Health Center Drug Pricing Protection Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53768,"prefix":null,"prefix_display":null,"first_name":"MAUREEN","nickname":null,"middle_name":null,"last_name":"TESTONI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148295,"prefix":null,"prefix_display":null,"first_name":"GARRETT","nickname":null,"middle_name":null,"last_name":"EBERHARDT","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/6f4ebeac-0efa-4edc-8892-1e6bf4912581/","filing_uuid":"6f4ebeac-0efa-4edc-8892-1e6bf4912581","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/6f4ebeac-0efa-4edc-8892-1e6bf4912581/print/","filing_document_content_type":"text/html","income":null,"expenses":"2580000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jesse Kerns","dt_posted":"2026-04-20T16:12:19-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th Street, NW","registrant_address_2":"11th Floor North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":3867,"url":"https://lda.gov/api/v1/registrants/3867/","house_registrant_id":31560,"name":"AMGEN, INC.","description":null,"address_1":"601 13th Street, NW","address_2":"11th Floor North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GREG PORTNER","contact_telephone":"+1 202-585-9500","dt_updated":"2026-07-30T12:38:37.840722-04:00"},"client":{"id":103709,"url":"https://lda.gov/api/v1/clients/103709/","client_id":12,"name":"AMGEN INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Act S 3510 Biosimilar Inspection Modernization Act PL 119-75 Consolidated Appropriations Act of 2026 HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 S 3788 Clear Labels Act HR 5256 340B Access Act H.R.5526 Biosimilar Red Tape Elimination Act HR 7391 Community Health Center Drug Pricing Protection Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51959,"prefix":null,"prefix_display":null,"first_name":"RUTH","nickname":null,"middle_name":null,"last_name":"HOFFMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147845,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"PETTIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to reimbursement for biologics/biosimilars Issues related to PBM reform Issues related to bone disease awareness and treatment HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S.3345, PBM Price Transparency and Accountability Act HR 6166, Lowering Drug Costs for American Families Act S 3019 - No Big Blockbuster Bailouts Act S 3349 PBM Disclosure Act HR 4317 PBM Reform Act Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act (EPIC) HR 1672 Maintaining Investments in New Innovation Act (MINI) HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 PL 119-75 Consolidated Appropriations Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51959,"prefix":null,"prefix_display":null,"first_name":"RUTH","nickname":null,"middle_name":null,"last_name":"HOFFMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147845,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"PETTIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate and international tax Public Law 115-97, Tax Cuts and Jobs Act Public Law 119-21, One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) Issues related to Puerto Rico Issues related to OECD negotiations on the taxation of global income","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Federal Trade Commission related issues Issues related to the Patent Act, no specific bill Issues related to March-In/Bayh Dole, WTO/TRIPS Issues related to patent thickets Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S 708/ HR 1574 -- Realizing Engineering, Science and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 (RESTORE) S.1553/HR3160-- Promoting and Respecting Economically Viable American Innovation Act (PREVAIL) S. 1546/ HR 3152-- Patent Eligibility Restoration Act of 2025 (PERA) S 2276 / HR 3269 Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Issues related to tariffs Issues related to trade agreements S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e3beff28-2272-4f88-b28c-e7fa63e13ebd/","filing_uuid":"e3beff28-2272-4f88-b28c-e7fa63e13ebd","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e3beff28-2272-4f88-b28c-e7fa63e13ebd/print/","filing_document_content_type":"text/html","income":null,"expenses":"3510000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jane Adams","dt_posted":"2026-04-20T16:34:13-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"ONE JOHNSON & JOHNSON PLAZA","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"NEW BRUNSWICK","registrant_state":"NJ","registrant_zip":"08933","registrant":{"id":20686,"url":"https://lda.gov/api/v1/registrants/20686/","house_registrant_id":30348,"name":"JOHNSON & JOHNSON SERVICES, INC.","description":null,"address_1":"ONE JOHNSON & JOHNSON PLAZA","address_2":null,"address_3":null,"address_4":null,"city":"NEW BRUNSWICK","state":"NJ","state_display":"New Jersey","zip":"08933","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JANE ADAMS","contact_telephone":"+1 202-589-1000","dt_updated":"2026-07-30T18:01:40.268804-04:00"},"client":{"id":126906,"url":"https://lda.gov/api/v1/clients/126906/","client_id":12,"name":"JOHNSON & JOHNSON SERVICES INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":91402,"prefix":null,"prefix_display":null,"first_name":"DEANA","nickname":null,"middle_name":null,"last_name":"MCRAE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71075,"prefix":null,"prefix_display":null,"first_name":"LARRY","nickname":null,"middle_name":null,"last_name":"CAMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73113,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"PINKELE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150724,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":null,"last_name":"KALUSNIAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153683,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"LAST","suffix":null,"suffix_display":null},"covered_position":"Sen. PA, Senate HELP Committee (2025); PA, Sen. Cornyn (2017-2022, 2023-2025); Sen. LA, Rep. Brady (2017); Sen. LA, Rep. Lance (2009-2012); LC/LA Rep. Knollenberg (2006-2008).","new":true},{"lobbyist":{"id":153684,"prefix":null,"prefix_display":null,"first_name":"FOLASHADE","nickname":null,"middle_name":null,"last_name":"WILSON","suffix":null,"suffix_display":null},"covered_position":"Health Fellow, Office of Robin Kelly (Sept 2024-Sept 2025); Health Fellow, Office of Bernard Sanders (Sept 2024-Oct 2025).","new":true},{"lobbyist":{"id":153685,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"CLARKIN","suffix":null,"suffix_display":null},"covered_position":"Legislative Director for Rep. Brian Fitzpatrick (March 2025-January 2026)","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"- Issues related to stroke care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"- H.R. 2483, \"SUPPORT for Patients and Communities Reauthorization Act of 2025\", regarding all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Issues related to - artificial intelligence - data privacy - cybersecurity - robotics","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax - use of excess pension funds","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":91402,"prefix":null,"prefix_display":null,"first_name":"DEANA","nickname":null,"middle_name":null,"last_name":"MCRAE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"- Issues related to USMCA review and renegotiation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/50f063a1-c512-49cc-a184-b0ffd4318012/","filing_uuid":"50f063a1-c512-49cc-a184-b0ffd4318012","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/50f063a1-c512-49cc-a184-b0ffd4318012/print/","filing_document_content_type":"text/html","income":null,"expenses":"85000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Stephanie Krenrich","dt_posted":"2026-04-20T16:54:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1575 I St NW","registrant_address_2":"Suite 300","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106566,"url":"https://lda.gov/api/v1/registrants/401106566/","house_registrant_id":45603,"name":"ADVOCATES FOR COMMUNITY HEALTH","description":null,"address_1":"1575 I St NW","address_2":"Suite 300","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MOLLY GRADY","contact_telephone":"+1 202-839-1869","dt_updated":"2026-10-20T12:02:31.689240-04:00"},"client":{"id":51652,"url":"https://lda.gov/api/v1/clients/51652/","client_id":51652,"name":"ADVOCATES FOR COMMUNITY HEALTH","general_description":"Membership org focused on policy and advocacy initiatives for the health care system","client_government_entity":null,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-05-20"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 7148, the Consolidated Appropriations Act, 2026 Issues related to the Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2027, especially funding for the Community Health Center Program and the National Health Service Corps H.R.1 One Big Beautiful Bill Act implementation, specifically state-based operations to implement the Rural Health Transformation Program and Medicaid changes, like community engagement requirements and new limits to funding mechanisms 340B Drug Pricing Program legislation, including the SUSTAIN Act, 340B Patients Act (HR 4581), the Community Health Center Drug Pricing Protection Act (HR 7391), and proposed 340C legislation Comments and legislative efforts to block 340B Rebate Model efforts and manufacturers efforts to compel claims data, including meetings with CMS and OMB Statement submitted to the House Committee on Budgets hearing, Reverse the Curse: Skyrocketing Health Care Costs and Americas Fiscal Future RFI Response to Congressional Doctors Caucuses on Proposed Payment Reforms Submitted comments to the Department of Education Re: Reimagining and Improving Student Education Proposed Rule, 34 CFR Parts 674, 682, and 685 [Docket ID ED-2025-OPE-0944] RIN 1840-AD98 Issues and legislation related to the primary care workforce, including advancing the Developing the Community Health Workforce Act, the Health Workforce Innovation Act (HR935), H-1Bs for Physicians and the Healthcare Workforce Act (HR7961), the Community TEAMS Act of 2025 (HR3885), funding for Title 7 & Title 8 workforce programs and activities related to a new workforce coalition, The Alliance to Strengthen Americas Health Workforce for the Underserved Issues related to CMMI models and health center participation in value-based care payment arrangements, including MAHA Elevate, ACCESS, and LEAD Issues related to the Health Center Community Transformation Hub Act (Has not been reintroduced in 119th Congress) Issues related to the Trump Administrations stance on community health centers and primary care workforce funding, including the Make America Healthy Again agenda (nutrition and chronic disease management)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141427,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"KRENRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144667,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"GRADY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/67b5714f-7362-43a2-86fd-22759280fe17/","filing_uuid":"67b5714f-7362-43a2-86fd-22759280fe17","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/67b5714f-7362-43a2-86fd-22759280fe17/print/","filing_document_content_type":"text/html","income":null,"expenses":"890000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brent Fisk","dt_posted":"2026-07-16T16:09:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 F STREET, NW, #480","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":16293,"url":"https://lda.gov/api/v1/registrants/16293/","house_registrant_id":31461,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","description":"PHARMACEUTICALS","address_1":"1201 F STREET, NW, #480","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FISK","contact_telephone":"+1 703-501-8920","dt_updated":"2026-10-05T10:48:35.722200-04:00"},"client":{"id":121722,"url":"https://lda.gov/api/v1/clients/121722/","client_id":12,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Presidents Budget Fiscal Year 2027 H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 4: Rescissions Act of 2025 (Public Law 119-28) H.R. 4121: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 S. ___: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027 H. Res. 566: Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14 H.R. 9310: Department of Homeland Security Appropriations Act, 2027 S. 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R. 9260: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 S._____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R. 5342: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 H.R. 6938: Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 (P.L. 119-74) H.R. 8845: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. ___: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 S. 2354: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 S. 1071: National Defense Authorization Act for Fiscal Year 2026 (Public Law No: 119-60) S. 2296: National Defense Authorization Act for Fiscal Year 2026 H.R. 8800: National Defense Authorization Act for Fiscal Year 2027 S. 4784: National Defense Authorization Act for Fiscal Year 2027 S. 2: Secure America Act (Public Law 119-18) H.R. 7148: Consolidated Appropriations Act, 2026 (Public Law 119-75) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Government funding policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":113,"name":"Patent & Trademark Office (PTO)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 355: FDA Modernization Act 3.0 S. 652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) S. 2658: Medication Affordability and Patent Integrity Act S. 3014: Ensuring Timely Access to Generics Act of 2025 S. 3345: PBM Price Transparency and Accountability Act S. 3788: CLEAR LABELS Act H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) H.R. 946: ORPHAN Cures Act H.R. 1262: Mikaela Naylon Give Kids a Chance Act H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2214: DRUG Act H.R. 3521: Clinical Trial Modernization Act H.R. 4317: PBM Reform Act of 2025 H.R. 5256: 340B ACCESS Act HR 5509, Safe Step Act, Provisions related step therapy protocols H.R. 6423: HELP Copays Act H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] H.R. 7837: Most Favored Patients Act H.R. 7391, the Community Health Center Drug Pricing Protection Act H.R. 7953: FAIR ACT H.R. 8269: CLEAR LABELS Act Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues IRA price negotiation expansion policy issues Pharmacy Benefit Manager reform and policy issues Drug cost and pricing policy issues Most Favored Nation (MFN) policy issues Drug importation policy issues FDA policy issues Competition policy issues Orphan Drug Act policy issues Antimicrobial resistance policy issues Compounding policy issues Supply chain policy issues Clinical trial policy issues 340B drug discount program rebate and policy issues 340B rebate pilot program Patient assistance program policy issues Biosimilar approval and reimbursement policy issues Drug shortages policy issues  Artificial intelligence policy issues Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Executive Order: Lowering Drug Prices by Once Again Putting Americans First S. 891, Bipartisan Health Care Act (including section 227 - Modernizing and Ensuring PBM Accountability) S.4784, An original bill to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes, Provisions related to the pharmaceutical industry. Smucker's VICP bill Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act (draft) Vaccine policy issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1: One Big Beautiful Bill Act (Public Law No. 119-21) Inflation Reduction Act of 2022 (P.L. 117-169) implementation policy issues Part D redesign and policy issues including non-interference and rebates policy issues Part B policy issues Drug cost and pricing policy issues Medicare rebate policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues CMS IPAY Guidance on the Medicare Drug Price Negotiation Program IPAY and Maximum Fair Prices policy issues Medicaid rebate policy issues GENErating cost Reductions for U.S. Medicaid (GENEROUS) model Global Benchmark for Efficient Drug Pricing (GLOBE) Proposed Rule Guarding U.S. Medicare Against Rising Drugs Costs (GUARD) Proposed Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proclamation: Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States (April 2, 2026) S. 2296: BIOSECURE Act (S.Amdt. 3236 to National Defense Authorization Act for FY 2026) H.R. 4780: USTRx Act H.R. 9102: Biotech Investment National Security Act (BINSA) H.R. 9142: Prohibiting Adversarial Patents Act of 2026 (PAPA) Executive Order: Delivering Most-Favored Nation Prescription Drug Pricing to American Patients Tariff policy issues Most Favored Nation (MFN) policy issues Biopharmaceutical innovation policy issues International intellectual property and market access policy issues Pricing and reimbursement policy issues Supply chain policy issues WTO TRIPS waiver policy issues COINS Act implementation policy issues China outbound investment policy issues including COINS Act US-UK Framework Agreement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147079,"prefix":null,"prefix_display":null,"first_name":"LIAM","nickname":null,"middle_name":null,"last_name":"MACDONALD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147862,"prefix":null,"prefix_display":null,"first_name":"HARMEET","nickname":null,"middle_name":null,"last_name":"DHILLON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151996,"prefix":null,"prefix_display":null,"first_name":"BRENTON","nickname":null,"middle_name":null,"last_name":"FISK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154302,"prefix":null,"prefix_display":null,"first_name":"JASEY","nickname":null,"middle_name":null,"last_name":"CARDENAS","suffix":null,"suffix_display":null},"covered_position":"Cong. Filemon Vela, Fellow, Staff Asst/Leg Correspondent, Leg Asst. 2014-2016","new":true},{"lobbyist":{"id":154303,"prefix":null,"prefix_display":null,"first_name":"CARA","nickname":null,"middle_name":null,"last_name":"WALTHER","suffix":null,"suffix_display":null},"covered_position":"Cong. Marsha Blackburn, Intern, Sept. 2016-Dec. 2016 Cong. Devin Nunes, Intern, Jan. 2017-Feb. 2017","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e66bad40-e50e-40ef-928b-f2d2e3a08469/","filing_uuid":"e66bad40-e50e-40ef-928b-f2d2e3a08469","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/e66bad40-e50e-40ef-928b-f2d2e3a08469/print/","filing_document_content_type":"text/html","income":null,"expenses":"240000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Garrett Eberhardt","dt_posted":"2026-07-20T11:34:15-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1350 I Street NW","registrant_address_2":"Suite 800","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":316434,"url":"https://lda.gov/api/v1/registrants/316434/","house_registrant_id":39137,"name":"340B HEALTH","description":"A non-profit hospital association representing hospitals enrolled in the 340B program.","address_1":"1350 I Street NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PATRICK MCGARY","contact_telephone":"+1 202-552-5820","dt_updated":"2026-07-27T13:55:36.949437-04:00"},"client":{"id":185829,"url":"https://lda.gov/api/v1/clients/185829/","client_id":12,"name":"340B HEALTH","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2015-05-06"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"The SECURE 340B Act (H.R. 9599); The Tax-Exempt Hospital Transparency Act (H.R.9504); 340B PATIENTS Act (H.R. 4581/S.2372); Community Health Center Drug Pricing Protection Act (H.R. 7391); 2027 OPPS Proposed Rule; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW; Manufacturer Demand for Access to in-House Pharmacy Claims Data; Lilly 340B Drug Pricing Denial; HRSA Rebate Model Pilot pending regulation; Pending Senate \"Gang of Six\" draft 340B legislation; FY27 Appropriations legislation; Pending introduction of updated and expanded Community Health Center Drug Pricing Protection Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53768,"prefix":null,"prefix_display":null,"first_name":"MAUREEN","nickname":null,"middle_name":null,"last_name":"TESTONI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148295,"prefix":null,"prefix_display":null,"first_name":"GARRETT","nickname":null,"middle_name":null,"last_name":"EBERHARDT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154452,"prefix":null,"prefix_display":null,"first_name":"RHEA","nickname":null,"middle_name":null,"last_name":"RACHO","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154719,"prefix":"ms","prefix_display":"MS.","first_name":"KENDALL","nickname":null,"middle_name":"ANNE","last_name":"CAIRNS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/dd31025d-92a7-4fb3-87ab-b3fc6ae1d498/","filing_uuid":"dd31025d-92a7-4fb3-87ab-b3fc6ae1d498","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/dd31025d-92a7-4fb3-87ab-b3fc6ae1d498/print/","filing_document_content_type":"text/html","income":null,"expenses":"1880000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jennie Skelton","dt_posted":"2026-07-20T12:39:34-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1275 Pennsylvania Avenue, NW","registrant_address_2":"Suite 501","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31326,"url":"https://lda.gov/api/v1/registrants/31326/","house_registrant_id":31354,"name":"PFIZER INC.","description":"Biopharmaceuticals","address_1":"1275 Pennsylvania Avenue, NW","address_2":"Suite 501","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIE SKELTON","contact_telephone":"+1 415-903-2800","dt_updated":"2026-08-21T13:00:31.079287-04:00"},"client":{"id":138225,"url":"https://lda.gov/api/v1/clients/138225/","client_id":12,"name":"PFIZER INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-02-15"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Intellectual Property Protections and Policy S. 2658 - Medication Affordability and Patent Integrity Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Vaccine Coverage and Coverage Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Codification and Sec. 301 trade investigations FDA User Fee Agreements: 2027 PDUFA Cycle H.R. 7837 - Most Favored Patient Act of 2026 H.R. 7391 - Community Health Center Drug Pricing Protection Act 340B Program Reform Inflation Reduction Act (IRA) H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriates Act, 2027 H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriation Act, 2027 H.R. 5178 - Sickle Cell Disease Comprehensive Care Act H.R. 5526 - Biosimilars Red Tape Elimination Act H.R. 4930 - To Expand the Sharing of Information with Respect to Suspected Violations of Intellectual Property Rights in Trade H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act: IRA reforms Prior Authorization Step Therapy Practices FDA Modernization and Reforms Drug Pricing PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106110,"prefix":null,"prefix_display":null,"first_name":"FRANCISCO","nickname":null,"middle_name":null,"last_name":"CARRILLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 7391 - Community Health Center Drug Pricing Protection Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Vaccine Access and Coverage 340B Program Reform PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage Step Therapy Practices Drug Pricing Medicare/Medicaid Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106110,"prefix":null,"prefix_display":null,"first_name":"FRANCISCO","nickname":null,"middle_name":null,"last_name":"CARRILLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1 - An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"H.R. 9102 - Biotech Investment National Security Act (BINSA) Act: US Competitiveness, Biotechnology H.R. 4930 - To Expand the Sharing of Information with Respect to Suspected Violations of Intellectual Property Rights in Trade International Supply Chain Section 301 Investigation re: Germany Issues Market Access Most Favored Nation Policies Foreign Freeriding Issues Non-Tariff Trade Barriers Competitiveness Issues Trade Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72512,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"CLAEYS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69774,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/dd31025d-92a7-4fb3-87ab-b3fc6ae1d498/","filing_uuid":"dd31025d-92a7-4fb3-87ab-b3fc6ae1d498","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/dd31025d-92a7-4fb3-87ab-b3fc6ae1d498/print/","filing_document_content_type":"text/html","income":null,"expenses":"1880000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jennie Skelton","dt_posted":"2026-07-20T12:39:34-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1275 Pennsylvania Avenue, NW","registrant_address_2":"Suite 501","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31326,"url":"https://lda.gov/api/v1/registrants/31326/","house_registrant_id":31354,"name":"PFIZER INC.","description":"Biopharmaceuticals","address_1":"1275 Pennsylvania Avenue, NW","address_2":"Suite 501","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIE SKELTON","contact_telephone":"+1 415-903-2800","dt_updated":"2026-08-21T13:00:31.079287-04:00"},"client":{"id":138225,"url":"https://lda.gov/api/v1/clients/138225/","client_id":12,"name":"PFIZER INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-02-15"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Intellectual Property Protections and Policy S. 2658 - Medication Affordability and Patent Integrity Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Vaccine Coverage and Coverage Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Codification and Sec. 301 trade investigations FDA User Fee Agreements: 2027 PDUFA Cycle H.R. 7837 - Most Favored Patient Act of 2026 H.R. 7391 - Community Health Center Drug Pricing Protection Act 340B Program Reform Inflation Reduction Act (IRA) H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriates Act, 2027 H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriation Act, 2027 H.R. 5178 - Sickle Cell Disease Comprehensive Care Act H.R. 5526 - Biosimilars Red Tape Elimination Act H.R. 4930 - To Expand the Sharing of Information with Respect to Suspected Violations of Intellectual Property Rights in Trade H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act: IRA reforms Prior Authorization Step Therapy Practices FDA Modernization and Reforms Drug Pricing PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106110,"prefix":null,"prefix_display":null,"first_name":"FRANCISCO","nickname":null,"middle_name":null,"last_name":"CARRILLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 7391 - Community Health Center Drug Pricing Protection Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Vaccine Access and Coverage 340B Program Reform PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage Step Therapy Practices Drug Pricing Medicare/Medicaid Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106110,"prefix":null,"prefix_display":null,"first_name":"FRANCISCO","nickname":null,"middle_name":null,"last_name":"CARRILLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1 - An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"H.R. 9102 - Biotech Investment National Security Act (BINSA) Act: US Competitiveness, Biotechnology H.R. 4930 - To Expand the Sharing of Information with Respect to Suspected Violations of Intellectual Property Rights in Trade International Supply Chain Section 301 Investigation re: Germany Issues Market Access Most Favored Nation Policies Foreign Freeriding Issues Non-Tariff Trade Barriers Competitiveness Issues Trade Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72512,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"CLAEYS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69774,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/31a9f398-c7a7-43ef-a970-78313480cf30/","filing_uuid":"31a9f398-c7a7-43ef-a970-78313480cf30","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/31a9f398-c7a7-43ef-a970-78313480cf30/print/","filing_document_content_type":"text/html","income":null,"expenses":"1440000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jane Adams","dt_posted":"2026-07-20T16:01:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"ONE JOHNSON & JOHNSON PLAZA","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"NEW BRUNSWICK","registrant_state":"NJ","registrant_zip":"08933","registrant":{"id":20686,"url":"https://lda.gov/api/v1/registrants/20686/","house_registrant_id":30348,"name":"JOHNSON & JOHNSON SERVICES, INC.","description":null,"address_1":"ONE JOHNSON & JOHNSON PLAZA","address_2":null,"address_3":null,"address_4":null,"city":"NEW BRUNSWICK","state":"NJ","state_display":"New Jersey","zip":"08933","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JANE ADAMS","contact_telephone":"+1 202-589-1000","dt_updated":"2026-07-30T18:01:40.268804-04:00"},"client":{"id":126906,"url":"https://lda.gov/api/v1/clients/126906/","client_id":12,"name":"JOHNSON & JOHNSON SERVICES INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"S.4784/H.R. 8800 National Defense Authorization Act (NDAA), regarding provision prohibiting Department of Defense (DOD) contracted companies from engaging in stock buybacks and issuing shareholder dividends absent a waiver from the Secretary","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71075,"prefix":null,"prefix_display":null,"first_name":"LARRY","nickname":null,"middle_name":null,"last_name":"CAMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71075,"prefix":null,"prefix_display":null,"first_name":"LARRY","nickname":null,"middle_name":null,"last_name":"CAMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73113,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"PINKELE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150724,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":null,"last_name":"KALUSNIAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153683,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"LAST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153684,"prefix":null,"prefix_display":null,"first_name":"FOLASHADE","nickname":null,"middle_name":null,"last_name":"WILSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153685,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"CLARKIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"- Issues related to stroke care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153685,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"CLARKIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"- H.R. 2483, \"SUPPORT for Patients and Communities Reauthorization Act of 2025\", regarding all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"H.R.8413, the SECURE Data Act, regarding all provisions Issues related to - artificial intelligence - data privacy - cybersecurity - robotics","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax - use of excess pension funds","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"- Issues related to USMCA review and renegotiation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e2da4764-9942-4a58-bb71-5df6a3fc754f/","filing_uuid":"e2da4764-9942-4a58-bb71-5df6a3fc754f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/e2da4764-9942-4a58-bb71-5df6a3fc754f/print/","filing_document_content_type":"text/html","income":null,"expenses":"2440000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jesse Kerns","dt_posted":"2026-07-20T16:02:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th Street, NW","registrant_address_2":"11th Floor North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":3867,"url":"https://lda.gov/api/v1/registrants/3867/","house_registrant_id":31560,"name":"AMGEN, INC.","description":null,"address_1":"601 13th Street, NW","address_2":"11th Floor North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GREG PORTNER","contact_telephone":"+1 202-585-9500","dt_updated":"2026-07-30T12:38:37.840722-04:00"},"client":{"id":103709,"url":"https://lda.gov/api/v1/clients/103709/","client_id":12,"name":"AMGEN INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act H.R.5526 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Act S 3510 Biosimilar Inspection Modernization Act PL 119-75 Consolidated Appropriations Act of 2026 HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 S 3788 Clear Labels Act HR 5256 340B Access Act HR 7391 Community Health Center Drug Pricing Protection Act HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act (Reconciliation 2.0) S 3014 Ensuring Timely Access to Generics Act of 2025 S 2355 Patients Deserve Price Tags Act HR 8646 Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 HR 8800 National Defense Authorization Act for Fiscal year 2027 HR 9102 BINSA Bill COINS Act, enacted within P.L. 119-60 National Defense Authorization Act for Fiscal Year 2026 S 1414 Expedited Access to Biosimilars Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51959,"prefix":null,"prefix_display":null,"first_name":"RUTH","nickname":null,"middle_name":null,"last_name":"HOFFMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147845,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"PETTIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to reimbursement for biologics/biosimilars Issues related to PBM reform Issues related to bone disease awareness and treatment S.3345, PBM Price Transparency and Accountability Act HR 6166, Lowering Drug Costs for American Families Act S 3019 - No Big Blockbuster Bailouts Act S 3349 PBM Disclosure Act HR 4317 PBM Reform Act Issues related to Public law 117-1769 Inflation Reduction Act HR 1672 Maintaining Investments in New Innovation Act (MINI) HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 PL 119-75 Consolidated Appropriations Act of 2026 HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51959,"prefix":null,"prefix_display":null,"first_name":"RUTH","nickname":null,"middle_name":null,"last_name":"HOFFMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147845,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"PETTIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate and international tax Public Law 115-97, Tax Cuts and Jobs Act Public Law 119-21, One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) Issues related to Puerto Rico Issues related to OECD negotiations on the taxation of global income","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Federal Trade Commission related issues Issues related to the Patent Act, no specific bill Issues related to March-In/Bayh Dole, WTO/TRIPS Issues related to patent thickets Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S 708/ HR 1574 -- Realizing Engineering, Science and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 (RESTORE) S.1553/HR3160-- Promoting and Respecting Economically Viable American Innovation Act (PREVAIL) S. 1546/ HR 3152-- Patent Eligibility Restoration Act of 2025 (PERA) S 2276 / HR 3269 Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Issues related to tariffs Issues related to trade agreements S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3730442f-7e1c-4dab-bb26-f429e6af0618/","filing_uuid":"3730442f-7e1c-4dab-bb26-f429e6af0618","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/3730442f-7e1c-4dab-bb26-f429e6af0618/print/","filing_document_content_type":"text/html","income":null,"expenses":"65000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Stephanie Krenrich","dt_posted":"2026-10-20T12:26:16-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1575 I St NW","registrant_address_2":"Suite 300","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106566,"url":"https://lda.gov/api/v1/registrants/401106566/","house_registrant_id":45603,"name":"ADVOCATES FOR COMMUNITY HEALTH","description":null,"address_1":"1575 I St NW","address_2":"Suite 300","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MOLLY GRADY","contact_telephone":"+1 202-839-1869","dt_updated":"2026-10-20T12:02:31.689240-04:00"},"client":{"id":51652,"url":"https://lda.gov/api/v1/clients/51652/","client_id":51652,"name":"ADVOCATES FOR COMMUNITY HEALTH","general_description":"Membership org focused on policy and advocacy initiatives for the health care system","client_government_entity":null,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-05-20"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Discretionary funding for the Health Center Program, the National Health Service Corps, and the Teaching Health Centers Graduate Medical Education Program that is funded via the Appropriations measure covering the Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for FY 2027 in both the House and the Senate. The Community Health Center Fund reauthorization; this \"extender\" must be reauthorized by December 31, 2026. Lobbying related to ACH's proposed CHC Value and Innovation Fund; H.R.1 One Big Beautiful Bill Act implementation, specifically state-based operations to implement the Rural Health Transformation Program and Community Engagement Requirements Issues related to CMS Interim Final Rule implementing Community Engagement Requirements & Notice of Proposed Rulemaking for Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments. H.R. 10398, the Community Health Center Reforms Enabling Better Access for Seniors and Elders (CHC REBASE) Act. Medicare/Duals issues including Medicare PPS payments, the PACE program, and telehealth flexibilities in the Medicare program. 340B Drug Pricing Program legislation, including HR 10770, the 340B Rebate Model Delay Act; HR 5244, the SUSTAIN 340B Act; HR 9599, the SECURE 340B Act; the 340B Patients Act (S 2372 & HR 4581); the Community Health Center Drug Pricing Protection Act (HR 7391). Comments and legislative efforts to block 340B Rebate Model Pilot Program efforts and manufacturers efforts to compel claims data Issues and legislation related to the primary care workforce, including the Developing the Community Health Workforce Act (HR8629), the Health Workforce Innovation Act (HR935), H-1Bs for Physicians and the Healthcare Workforce Act (HR7961), the Community TEAMS Act of 2025 (HR3885), funding for Title 7 & Title 8 workforce programs and activities related to a new workforce coalition, The Alliance to Strengthen Americas Health Workforce for the Underserved Issues related to CMMI models and health center participation in value-based care payment arrangements, including MAHA Elevate, ACCESS, and LEAD Issues related to the Health Center Community Transformation Hub Act (Has not been reintroduced in 119th Congress) Issues related to the Trump Administrations stance on community health centers and primary care workforce funding, including the Make America Healthy Again agenda (nutrition and chronic disease management). Legislation being developed by Senator Warnock to establish an HRSA grant program to help Section 330 grantees maintain and modernize mobile units.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141427,"prefix":null,"prefix_display":null,"first_name":"STEPHANIE","nickname":null,"middle_name":null,"last_name":"KRENRICH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/4612a5cf-75e2-4b51-8827-540cc0bafdb5/","filing_uuid":"4612a5cf-75e2-4b51-8827-540cc0bafdb5","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/4612a5cf-75e2-4b51-8827-540cc0bafdb5/print/","filing_document_content_type":"text/html","income":null,"expenses":"2220000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jane Adams","dt_posted":"2026-10-20T15:14:18-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"ONE JOHNSON & JOHNSON PLAZA","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"NEW BRUNSWICK","registrant_state":"NJ","registrant_zip":"08933","registrant":{"id":20686,"url":"https://lda.gov/api/v1/registrants/20686/","house_registrant_id":30348,"name":"JOHNSON & JOHNSON SERVICES, INC.","description":null,"address_1":"ONE JOHNSON & JOHNSON PLAZA","address_2":null,"address_3":null,"address_4":null,"city":"NEW BRUNSWICK","state":"NJ","state_display":"New Jersey","zip":"08933","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JANE ADAMS","contact_telephone":"+1 202-589-1000","dt_updated":"2026-07-30T18:01:40.268804-04:00"},"client":{"id":126906,"url":"https://lda.gov/api/v1/clients/126906/","client_id":12,"name":"JOHNSON & JOHNSON SERVICES INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act, regarding all provisions - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions - H.R. 3953 / S. 1874 Title VIII Nursing Workforce Reauthorization Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71075,"prefix":null,"prefix_display":null,"first_name":"LARRY","nickname":null,"middle_name":null,"last_name":"CAMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73113,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"PINKELE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150724,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":null,"last_name":"KALUSNIAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153683,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"LAST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153684,"prefix":null,"prefix_display":null,"first_name":"FOLASHADE","nickname":null,"middle_name":null,"last_name":"WILSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153685,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"CLARKIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"- Issues related to stroke care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act, regarding all provisions Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153685,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"CLARKIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding, regarding all provisions - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding, regarding all provisions","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"- H.R. 2483, \"SUPPORT for Patients and Communities Reauthorization Act of 2025\", regarding all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"H.R.8413, the SECURE Data Act, regarding all provisions Issues related to - artificial intelligence - data privacy - cybersecurity - robotics","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax - S. 2003, the \"Strengthening Benefits Plans Act\", provisions on use of excess pension funds","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"- Issues related to USMCA review and renegotiation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"- S.4784/H.R. 8800 National Defense Authorization Act (NDAA), regarding provision prohibiting Department of Defense (DOD) contracted companies from engaging in stock buybacks and issuing shareholder dividends absent a waiver from the Secretary","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71075,"prefix":null,"prefix_display":null,"first_name":"LARRY","nickname":null,"middle_name":null,"last_name":"CAMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153684,"prefix":null,"prefix_display":null,"first_name":"FOLASHADE","nickname":null,"middle_name":null,"last_name":"WILSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/57575736-484a-471b-916b-2b2bf41eb4fe/","filing_uuid":"57575736-484a-471b-916b-2b2bf41eb4fe","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/57575736-484a-471b-916b-2b2bf41eb4fe/print/","filing_document_content_type":"text/html","income":null,"expenses":"3150000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jesse Kerns","dt_posted":"2026-10-20T16:03:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th Street, NW","registrant_address_2":"11th Floor North","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":3867,"url":"https://lda.gov/api/v1/registrants/3867/","house_registrant_id":31560,"name":"AMGEN, INC.","description":null,"address_1":"601 13th Street, NW","address_2":"11th Floor North","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GREG PORTNER","contact_telephone":"+1 202-585-9500","dt_updated":"2026-07-30T12:38:37.840722-04:00"},"client":{"id":103709,"url":"https://lda.gov/api/v1/clients/103709/","client_id":12,"name":"AMGEN INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to reimbursement for biologics/biosimilars Issues related to PBM reform Issues related to bone disease awareness and treatment S.3345, PBM Price Transparency and Accountability Act HR 6166, Lowering Drug Costs for American Families Act S 3019 - No Big Blockbuster Bailouts Act S 3349 PBM Disclosure Act HR 4317 PBM Reform Act Issues related to Public law 117-1769 Inflation Reduction Act HR 1672 Maintaining Investments in New Innovation Act (MINI) HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 PL 119-75 Consolidated Appropriations Act of 2026 HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act HR 10628/ S 5571 Biosimilars Access and Affordability Act S 5244 Sustain 340B Act HR 9599 Secure 340B Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51959,"prefix":null,"prefix_display":null,"first_name":"RUTH","nickname":null,"middle_name":null,"last_name":"HOFFMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147845,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"PETTIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate and international tax Public Law 115-97, Tax Cuts and Jobs Act Public Law 119-21, One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) Issues related to Puerto Rico Issues related to OECD negotiations on the taxation of global income","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to drug pricing Issues related to cardiovascular disease awareness and treatment Issues related to FDA Issues related to patient affordability issues, including copay cards, copay accumulators, copay maximizers, National Benefit Payment Parameters Issues related to biosimilars reimbursement Issues related to Supply Chain Issues related to 340B Issues related to pharmacy benefit managers Issues related to biosimilars regulatory standards Issues related to bone disease awareness and treatment Issues related to Public law 117-1769 Inflation Reduction Act HR 1492 Ensuring Pathways to Innovative Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act H.R.5526 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform Act S 3510 Biosimilar Inspection Modernization Act PL 119-75 Consolidated Appropriations Act of 2026 HR 4299 Protecting Patient Access to Cancer and Complex Therapies Act H.R.7837 Most Favored Patient Act of 2026 S 3788 Clear Labels Act HR 5256 340B Access Act HR 7391 Community Health Center Drug Pricing Protection Act HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act (Reconciliation 2.0) S 3014 Ensuring Timely Access to Generics Act of 2025 S 2355 Patients Deserve Price Tags Act HR 8646 Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 HR 8800 National Defense Authorization Act for Fiscal year 2027 HR 9102 BINSA Bill COINS Act, enacted within P.L. 119-60 National Defense Authorization Act for Fiscal Year 2026 S 1414 Expedited Access to Biosimilars Act HR 10628/ S 5571 Biosimilars Access and Affordability Act S 5244 Sustain 340B Act HR 9599 Secure 340B Act HR 5509/ S 2903 Safe Step Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147845,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"PETTIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51959,"prefix":null,"prefix_display":null,"first_name":"RUTH","nickname":null,"middle_name":null,"last_name":"HOFFMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Federal Trade Commission related issues Issues related to the Patent Act, no specific bill Issues related to March-In/Bayh Dole, WTO/TRIPS Issues related to patent thickets Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S 708/ HR 1574 -- Realizing Engineering, Science and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 (RESTORE) S.1553/HR3160-- Promoting and Respecting Economically Viable American Innovation Act (PREVAIL) S. 1546/ HR 3152-- Patent Eligibility Restoration Act of 2025 (PERA) S 2276 / HR 3269 Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Issues related to tariffs Issues related to trade agreements S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33334,"prefix":null,"prefix_display":null,"first_name":"L","nickname":null,"middle_name":"NICOLE","last_name":"CURRIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":33612,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"O'BRIEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":36188,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"RHEE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144960,"prefix":"ms","prefix_display":"MS.","first_name":"KIMBERLY","nickname":null,"middle_name":null,"last_name":"LOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138086,"prefix":"mrs","prefix_display":"MRS.","first_name":"JORDAN","nickname":null,"middle_name":"LYNN","last_name":"LAYSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18761,"prefix":null,"prefix_display":null,"first_name":"HOWARD","nickname":null,"middle_name":null,"last_name":"MOON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14859,"prefix":null,"prefix_display":null,"first_name":"JESSE","nickname":null,"middle_name":null,"last_name":"KERNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147106,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MCMURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147846,"prefix":null,"prefix_display":null,"first_name":"CHASE","nickname":null,"middle_name":null,"last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13124,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"PORTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}